PAS
DSGN icon

Point72 Asia (Singapore)’s Design Therapeutics DSGN Stock Holding History

Point72 Asia (Singapore)’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$42.9K Buy
+5,702
New +$28.6K 0.01% 589
2024
Q3 		– Sell
-1,288
Closed -$4.32K – 1066
2024
Q2 		$4.32K Buy
+1,288
New +$5.02K ﹤0.01% 975
2024
Q1 		– Sell
-2,100
Closed -$5.57K – 1107
2023
Q4 		$5.57K Buy
+2,100
New +$4.81K ﹤0.01% 527

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asia (Singapore)'s DSGN Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Design Therapeutics (DSGN) in Q3 2025: 5,702 shares worth $42.9K. The stake represents 0.01% of the portfolio and ranks #589 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in DSGN as recently as Q2 2024.

Point72 Asia (Singapore) first reported a position in DSGN in Q4 2023 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold DSGN as of Q3 2025.

  • Point72 Asia (Singapore) held 5,702 shares of Design Therapeutics worth $42.9K as of Q3 2025.
  • Design Therapeutics was a new Point72 Asia (Singapore) position in Q3 2025.
  • Design Therapeutics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #589 holding.
  • Point72 Asia (Singapore) first reported a position in Design Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 95 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.